RAYMOND JAMES & ASSOCIATES - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$279,000
+39.5%
6,154
+8.7%
0.00%
Q3 2020$200,000
-7.4%
5,662
-1.1%
0.00%
Q2 2020$216,000
-29.4%
5,727
-3.0%
0.00%
Q4 2019$306,000
-6.4%
5,905
-1.0%
0.00%
Q3 2019$327,000
+9.7%
5,963
-18.8%
0.00%
Q2 2019$298,000
+27.9%
7,343
-4.9%
0.00%
Q1 2019$233,000
+13.1%
7,721
+26.1%
0.00%
Q4 2018$206,000
-33.8%
6,121
-17.1%
0.00%
Q3 2018$311,000
+26.9%
7,380
-3.6%
0.00%
Q2 2018$245,000
+18.4%
7,658
+84.1%
0.00%
Q1 2018$207,000
-37.1%
4,160
-69.8%
0.00%
-100.0%
Q3 2013$329,000
+46.9%
13,787
+4.6%
0.00%
+50.0%
Q2 2013$224,00013,1860.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Caligan Partners LP 591,675$17,513,58014.58%
Trigran Investments, Inc. 1,564,541$46,310,4134.64%
DIKER MANAGEMENT LLC 22,458$664,7570.77%
Virtus Fund Advisers, LLC 3,490$103,3040.74%
Portolan Capital Management 207,900$6,153,8400.61%
Virtus Investment Advisers, Inc. 16,086$476,1460.32%
Ranger Investment Management 140,205$4,150,0680.31%
BOOTHBAY FUND MANAGEMENT, LLC 367,510$10,878,2960.25%
Riverwater Partners LLC 9,778$289,4290.25%
Legato Capital Management LLC 7,556$223,6580.04%
View complete list of ANIKA THERAPEUTICS INC shareholders